Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Blue Cross Georgia Prilosec OTC coupons

This article was originally published in The Tan Sheet

Executive Summary

Wellpoint Health Networks expands coupon offerings for Prilosec OTC to its Blue Cross and Blue Shield Georgia members through a new coupon program, insurance provider announces Oct. 20. More than 25,000 insured members who have received proton pump inhibitor prescriptions will be sent information on the program, along with three Prilosec OTC coupons. Discounts include one free sample box of 14 pills and two $10 redemption coupons towards purchase of 28- or 42-count boxes. Coupons will reduce the cost of a one-month supply from $0.78 per tablet to $0.43 per tablet, BCBSGA estimates. Wellpoint has offered coupons for the drug through its California Blue Cross operating subsidiary as well (1"The Tan Sheet" Aug. 25, 2003, p. 6)...

You may also be interested in...

Blue Cross Michigan backs Prilosec OTC

Coupons offering $5 off the price of Prilosec OTC are now being mailed to 12,000 health plan members who could benefit from a discount on heartburn medication, Blue Cross Blue Shield of Michigan announces March 18. The cost of the coupon - which expires May 31, 2004 - is covered by the manufacturer, according to BCBSM. Similar discount programs supporting OTC use of Prilosec were undertaken in Fall 2003 by Blue Cross Blue Shield of Georgia and California (1"The Tan Sheet" Oct. 27, 2003, In Brief and 2"The Tan Sheet" Aug. 25, 2003, p. 6)...

Novartis Omeprazole Offering, Wellpoint, Prilosec OTC Pressure PPI Prices

Novartis' entrance into the OTC loratadine market in March could set a precedent for the firm to make a similar move with the proton pump inhibitor omeprazole

MDR Is The ‘Mother Of European Industry’s Problems’ − Germany's BVMed At Medica 2023

Higher logistics and energy costs are putting medtech P&Ls under pressure, and compliance with the EU MDR is draining any remaining surplus. Sustainability compliance is another cost to factor in, says BVMed chief executive Marc-Pierre Möll in part 2 of his interview with Medtech Insight at Medica 2023. 


Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts